|

Platinum based chemotherapy Clinical Trials

10 actively recruiting trials across 4 locations

▼ -1 trial since August 2026

Also known as: Cisplatin, pemetrexed, gemcitabine, carboplatin, paclitaxel, docetaxel, Standard of Care, albuminotaxol, carboplatin, cisplatin +4 more

Pipeline

Phase 2: 5Phase 3: 3Phase 1/2: 1

Top Sponsors

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
  • Zeng Jian1
  • Yonsei University1
  • Weill Medical College of Cornell University1
  • The First Affiliated Hospital of Guangzhou Medical University1

Indications

Other6 trials

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
Phase 2
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
Phase 2
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer
Phase 3
Neoadjuvant Treatment Modalities in Esophageal Cancer
Phase 3
Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy
Phase 2

Birmingham, Alabama1 trial

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Central Alabama Research

Phase 3

Los Angeles, California1 trial

Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

Valkyrie Clinical Trials

Phase 1/2

Miami, Florida1 trial

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

BAPTIST ALLIANCE - MCI (Data Collection Only)

Phase 2

New York, New York1 trial

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC

Weill Cornell Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.